Regulatory mechanisms of osteoblast and osteoclast differentiation.
暂无分享,去创建一个
[1] G Shimamoto,et al. Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.
[2] Naoya Yamamoto,et al. Constitutively active BMP type I receptors transduce BMP-2 signals without the ligand in C2C12 myoblasts. , 1997, Experimental cell research.
[3] V. Rosen,et al. Novel regulators of bone formation: molecular clones and activities. , 1988 .
[4] T. Chambers,et al. Activin A is an essential cofactor for osteoclast induction. , 2000, Biochemical and biophysical research communications.
[5] J. Wozney,et al. Runx2 Is a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2, and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12 , 2000, Molecular and Cellular Biology.
[6] N. Quinn. Rhythmic Tremor of the Palate and Other Cranial Limb Muscles, With Cerebellar Ataxia: Consider Whipple's Disease , 2001, Movement disorders : official journal of the Movement Disorder Society.
[7] D L Lacey,et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[8] S. Takeshita,et al. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. , 2000, The Journal of clinical investigation.
[9] D. Kingsley,et al. What do BMPs do in mammals? Clues from the mouse short-ear mutation. , 1994, Trends in genetics : TIG.
[10] T. Martin,et al. Osteoblastic cells are involved in osteoclast formation. , 1988, Endocrinology.
[11] R. Harland,et al. The Spemann Organizer Signal noggin Binds and Inactivates Bone Morphogenetic Protein 4 , 1996, Cell.
[12] K. Miyazono,et al. Interaction and Functional Cooperation of PEBP2/CBF with Smads , 1999, The Journal of Biological Chemistry.
[13] N. Udagawa,et al. Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells. , 1991, Endocrinology.
[14] N. Ueno,et al. A Kinase Domain-truncated Type I Receptor Blocks Bone Morphogenetic Protein-2-induced Signal Transduction in C2C12 Myoblasts* , 1997, The Journal of Biological Chemistry.
[15] J. Aubin,et al. Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell line. , 1990, Developmental biology.
[16] B. Aggarwal,et al. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. , 1999, The Journal of biological chemistry.
[17] V. Rosen,et al. Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] S. Nishikawa,et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.
[19] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[20] B. Hogan,et al. Skeletal abnormalities in doubly heterozygous Bmp4 and Bmp7 mice. , 1998, Developmental genetics.
[21] A. Bradley,et al. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. , 1995, Genes & development.
[22] L. Larivière,et al. Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) , 1999, The Journal of experimental medicine.
[23] Sakae Tanaka,et al. Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice , 1999, Genes to cells : devoted to molecular & cellular mechanisms.
[24] P. Sexton,et al. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF‐α, IL‐1, and RANKL , 2002, Journal of cellular physiology.
[25] R. Steinman,et al. The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor* , 1998, The Journal of Biological Chemistry.
[26] K. Yoshimura,et al. Heterotopic Ossification of Degenerating Rat Skeletal Muscle Induced by Adenovirus‐Mediated Transfer of Bone Morphogenetic Protein‐2 Gene , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[27] M. Owen,et al. Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia , 1997, Cell.
[28] G. Karsenty,et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. , 1999, Genes & development.
[29] K. Lyons,et al. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. , 1995, Genes & development.
[30] J. Deng,et al. The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.
[31] E. Wagner,et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. , 1994, Science.
[32] J. Caamaño,et al. Osteopetrosis in mice lacking NF-κB1 and NF-κB2 , 1997, Nature Medicine.
[33] B. Lanske,et al. The parathyroid hormone/parathyroid hormone-related peptide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] B. Lanske,et al. Conditionally immortalized murine bone marrow stromal cells mediate parathyroid hormone-dependent osteoclastogenesis in vitro. , 1998, Endocrinology.
[35] B. Hogan,et al. Mice lacking Bmp6 function. , 1998, Developmental genetics.
[36] S. Takeda,et al. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. , 2001, Genes & development.
[37] E. Jimi,et al. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. , 1999, Journal of immunology.
[38] K. Miyazono,et al. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. , 2001, Journal of cell science.
[39] A. Baldini,et al. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia , 1997, Nature Genetics.
[40] N. Copeland,et al. Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily , 1994, Nature.
[41] K. Miyazono,et al. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[42] T. Martin,et al. Modulation of osteoclast differentiation. , 1992, Endocrine reviews.
[43] J. Wrana. Regulation of Smad Activity , 2000, Cell.
[44] M. Wani,et al. A role for TGFbeta(1) in osteoclast differentiation and survival. , 2000, Journal of cell science.
[45] J. Lou,et al. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. , 2000, Biochemical and biophysical research communications.
[46] Joan Massagu,et al. How cells read TGF-|[beta]| signals , 2000 .
[47] T. Martin,et al. Tumor Necrosis Factor (cid:97) Stimulates Osteoclast Differentiation by a Mechanism Independent of the ODF/RANKL–RANK Interaction , 2022 .
[48] B. Aggarwal,et al. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. , 1998, The Journal of biological chemistry.
[49] T. Komori,et al. Cbfa1 Isoforms Exert Functional Differences in Osteoblast Differentiation* , 1999, The Journal of Biological Chemistry.
[50] G. Gross,et al. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. , 1993, DNA and cell biology.
[51] S. Morony,et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.
[52] D. Lacey,et al. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.
[53] Ulrich Siebenlist,et al. Requirement for NF-κB in osteoclast and B-cell development , 1997 .
[54] T. Martin,et al. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors , 1995, The Journal of experimental medicine.
[55] E. Jimi,et al. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. , 1996, Endocrinology.
[56] Frank P. Luyten,et al. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1 , 1997, Nature Genetics.
[57] J. Massagué,et al. GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex. , 1995, The EMBO journal.
[58] R. Baron,et al. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity. , 2000, Biochemical and biophysical research communications.
[59] V. Rosen,et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713] , 1994, The Journal of cell biology.
[60] V. Rosen,et al. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. , 1990, Biochemical and biophysical research communications.
[61] S. Mundlos,et al. Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development‐matrix components and their homeostasis , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[62] K. Miyazono. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. , 1999, Bone.
[63] K. Miyazono,et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[64] N. Ueno,et al. Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-κB Ligand. , 2001, Endocrinology.
[65] N. Udagawa,et al. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. , 1998, Biochemical and biophysical research communications.
[66] N. Kanatani,et al. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures , 2001, The Journal of cell biology.
[67] M. F. Macnicol. Patterns of musculoskeletal infection in childhood. , 2001, The Journal of bone and joint surgery. British volume.
[68] W. Dougall,et al. The Involvement of Multiple Tumor Necrosis Factor Receptor (TNFR)-associated Factors in the Signaling Mechanisms of Receptor Activator of NF-κB, a Member of the TNFR Superfamily* , 1998, The Journal of Biological Chemistry.
[69] Y. Sasai,et al. Dorsoventral Patterning in Xenopus: Inhibition of Ventral Signals by Direct Binding of Chordin to BMP-4 , 1996, Cell.
[70] Naoya Yamamoto,et al. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. , 1997, Biochemical and biophysical research communications.
[71] T. Suda. Modulation of osteoclast differentiation [published erratum appears in Endocr Rev 1992 May;13(2):191] , 1992 .
[72] K. Miyazono. TGF-β signaling by Smad proteins , 2000 .
[73] N. Copeland,et al. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGFβ superfamily , 1992, Cell.
[74] J. Woo,et al. Ca2+-ATPase inhibitors and Ca2+-ionophore induce osteoclast-like cell formation in the cocultures of mouse bone marrow cells and calvarial cells. , 1997, Biochemical and biophysical research communications.
[75] R. Dubose,et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function , 1997, Nature.
[76] W. Dougall,et al. RANK is essential for osteoclast and lymph node development. , 1999, Genes & development.
[77] S. Niida,et al. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor , 1991, The Journal of experimental medicine.
[78] D. Kingsley. Genetic control of bone and joint formation. , 2001, Novartis Foundation symposium.
[79] G. Rodan,et al. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. , 1999, Experimental cell research.
[80] J. Massagué,et al. How cells read TGF-β signals , 2000, Nature Reviews Molecular Cell Biology.
[81] Brian R. Wong,et al. TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells* , 1997, The Journal of Biological Chemistry.
[82] R. Harland,et al. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. , 1998, Molecular cell.
[83] E. Wagner,et al. Bone and haematopoietic defects in mice lacking c-fos , 1992, Nature.
[84] Leslie Dale,et al. Cleavage of Chordin by Xolloid Metalloprotease Suggests a Role for Proteolytic Processing in the Regulation of Spemann Organizer Activity , 1997, Cell.
[85] Helen M. Blau,et al. Cytoplasmic activation of human nuclear genes in stable heterocaryons , 1983, Cell.
[86] B. Hogan,et al. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.
[87] T. Martin,et al. Intracellular Calcium and Protein Kinase C Mediate Expression of Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin in Osteoblasts. , 2000, Endocrinology.
[88] Yigong Shi,et al. Structural insights on Smad function in TGFβ signaling , 2001 .
[89] C. Gatlin,et al. TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF. , 1999, Biochemical and biophysical research communications.
[90] T. Martin,et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[91] Sakae Tanaka,et al. Negative Regulation of BMP/Smad Signaling by Tob in Osteoblasts , 2000, Cell.
[92] A. Reddi. Bone Morphogenetic Proteins: From Basic Science to Clinical Applications , 2001, The Journal of bone and joint surgery. American volume.
[93] G. Karsenty. The genetic transformation of bone biology. , 1999, Genes & development.
[94] E. Jimi,et al. Regulation of Osteoclast Function , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[95] F. Lallemand,et al. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. , 2001, Bone.
[96] E. Wang,et al. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. , 1993, Growth factors.
[97] V. Rosen,et al. Differential Roles for Bone Morphogenetic Protein (BMP) Receptor Type IB and IA in Differentiation and Specification of Mesenchymal Precursor Cells to Osteoblast and Adipocyte Lineages , 1998, The Journal of cell biology.
[98] T. Komori,et al. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. , 2000, Endocrine reviews.
[99] V. Rosen,et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro , 1991, The Journal of cell biology.
[100] N Muthukumaran,et al. Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[101] T. Martin,et al. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. , 1989, Endocrinology.
[102] D. Greenspan,et al. Bone Morphogenetic Protein-1: The Type I Procollagen C-Proteinase , 1996, Science.
[103] Y. Ito,et al. Expression of the PEBP2alphaA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells. , 1998, Bone.
[104] S. Morony,et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. , 1999, Genes & development.
[105] J. Massagué,et al. Controlling TGF-β signaling , 2000, Genes & Development.
[106] K. Miyazono,et al. cDNA cloning and genomic organization of the mouse BMP type II receptor. , 1997, Biochemical and biophysical research communications.
[107] K Yano,et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[108] B. Kwon,et al. Receptor activator of NF‐κB recruits multiple TRAF family adaptors and activates c‐Jun N‐terminal kinase , 1999, FEBS letters.
[109] K. Miyazono,et al. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. , 1999, Science.
[110] S. Mckercher,et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1 , 1997, Nature.
[111] K. Miyazono,et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. , 1999, Molecular biology of the cell.
[112] M. Young,et al. Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. , 1992, Clinical orthopaedics and related research.
[113] T. Yoneda,et al. Smad5 and DPC4 Are Key Molecules in Mediating BMP-2-induced Osteoblastic Differentiation of the Pluripotent Mesenchymal Precursor Cell Line C2C12* , 1998, The Journal of Biological Chemistry.
[114] H. Uchiyama,et al. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[115] N. Kanatani,et al. Skeletal Malformations Caused by Overexpression of Cbfa1 or Its Dominant Negative Form in Chondrocytes , 2001, The Journal of cell biology.
[116] R. Wallace,et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis , 2000, Nature Genetics.
[117] T. Hefferan,et al. Structure and molecular regulation of bone matrix proteins , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[118] D. Lacey,et al. The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts , 1999, The Journal of cell biology.
[119] A. McMahon,et al. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. , 1998, Science.
[120] S. Mundlos,et al. Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.
[121] S. Takeda,et al. Stimulation of Osteoclast Formation by 1,25-Dihydroxyvitamin D Requires Its Binding to Vitamin D Receptor (VDR) in Osteoblastic Cells: Studies Using VDR Knockout Mice. , 1999, Endocrinology.
[122] K. Lyons,et al. Bone morphogenetic protein-3 is a negative regulator of bone density , 2001, Nature Genetics.
[123] M. Muenke,et al. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. , 1996, The New England journal of medicine.
[124] M. Urist. Bone: Formation by Autoinduction , 1965, Science.
[125] F. Luyten,et al. A human chondrodysplasia due to a mutation in a TGF-β superfamily member , 1996, Nature Genetics.
[126] J. Massagué,et al. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. , 1997, Genes & development.
[127] T. Sakou. Bone morphogenetic proteins: from basic studies to clinical approaches. , 1998, Bone.
[128] M. Cecchini,et al. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. , 1990, Endocrinology.
[129] V. Rosen,et al. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. , 1998, Clinical orthopaedics and related research.
[130] J. Aubin,et al. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone , 1988, The Journal of cell biology.
[131] T. Bouwmeester,et al. The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals , 1999, Nature.
[132] Se-Jin Lee,et al. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11 , 1999, Nature Genetics.
[133] Y. Azuma,et al. Tumor Necrosis Factor-α Induces Differentiation of and Bone Resorption by Osteoclasts* , 2000, The Journal of Biological Chemistry.
[134] S. Akira,et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.
[135] K. Nakao,et al. Crucial Involvement of the EP4 Subtype of Prostaglandin E Receptor in Osteoclast Formation by Proinflammatory Cytokines and Lipopolysaccharide , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[136] G. Karsenty,et al. Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.
[137] Makoto Sato,et al. Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.
[138] T. Katagiri,et al. Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4. , 1996, Bone.
[139] Peter A. Jones,et al. Multiple new phenotypes induced in 10T 1 2 and 3T3 cells treated with 5-azacytidine , 1979, Cell.
[140] S. Mochizuki,et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. , 1997, Biochemical and biophysical research communications.
[141] C. Niehrs,et al. Silencing of TGF-β signalling by the pseudoreceptor BAMBI , 1999, Nature.
[142] D. Yaffe,et al. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle , 1977, Nature.
[143] Yongwon Choi,et al. Osteoimmunology: Bone versus immune system , 2000, Nature.